Effect of mimetic CDK9 inhibitors on HIV-1-activated transcription.

Van Duyne R, Guendel I, Jaworski E, Sampey G, Klase Z, Chen H, Zeng C, Kovalskyy D, El Kouni MH, Lepene B, Patanarut A, Nekhai S, Price DH, Kashanchi F. Effect of mimetic CDK9 inhibitors on HIV-1-activated transcription. J Mol Biol. 2013 Feb 22; 425(4):812-29.

View in: PubMed

subject areas

Animals
Binding Sites
Blotting, Western
Cell Line
Cells, Cultured
Cyclin-Dependent Kinase 9
Disease Models, Animal
Female
Hela Cells
HIV Infections
HIV-1
Host-Pathogen Interactions
Humans
Leukocytes, Mononuclear
Male
Mice
Mice, Knockout
Models, Molecular
Molecular Structure
Protein Binding
Protein Kinase Inhibitors
Protein Structure, Tertiary
tat Gene Products, Human Immunodeficiency Virus
Transcriptional Activation
Virus Replication

authors with profiles

Sergei Nekhai

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support